Valuation: Nexentis Technologies Inc.

Market Cap 1.31M 1.13M 1.05M 964K 1.81M 126M 1.85M 12.46M 4.86M 63.05M 4.94M 4.83M 209M P/E 2024
-0.28x
P/E 2025 -0.34x
Enterprise Value -1.76M -1.51M -1.41M -1.29M -2.43M -169M -2.48M -16.72M -6.52M -84.6M -6.62M -6.48M -280M EV / Sales 2024
1.64x
EV / Sales 2025 -
Free-Float
78.83%
Yield 2024 *
-
Yield 2025 -
1 day-5.76%
1 week-7.69%
Current month+5.26%
1 month-21.40%
3 months-59.32%
6 months-72.35%
Current year-84.69%
1 week 1.8
Extreme 1.8
2
1 month 1.43
Extreme 1.4301
2.16
Current year 1.43
Extreme 1.4301
23.8
1 year 1.43
Extreme 1.4301
58.75
3 years 1.43
Extreme 1.4301
1,849.73
5 years 1.43
Extreme 1.4301
16,464.03
10 years 1.43
Extreme 1.4301
54,022.91
Manager TitleAgeSince
Chief Executive Officer 60 2020-11-04
Director of Finance/CFO 39 2022-04-17
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 53 2020-08-25
Chairman 62 2021-05-23
Director/Board Member 54 2020-08-25
Date Insider Type Main position Quantity % Market Cap.
2/9/26 Free

Chief Financial Officer

50,000 1.8639%
2/9/26 Free

Chairman

116,286 4.3350%
2/9/26 Free

Chief Executive Officer

100,000 3.7279%
Change 5-day change 1-year change 3-year change Capi.($)
-5.76%-7.69%-96.38%-99.85% 1.4M
+1.13%+4.84%+8.91%+56.54% 52.42B
+0.11%-.--%-.--%-.--% 12.96B
+0.33%+1.01%+23.87%+187.48% 10.56B
+0.13%+3.58%+10.69%+76.93% 8.07B
+0.36%+2.41%-11.11%-9.95% 7.1B
-2.78%+10.20%+51.88%+63.09% 5.88B
-1.80%-5.62%-23.81%+70.80% 5.33B
+0.37%+0.49%-20.03%-1.34% 5.02B
-0.26%+0.14%-34.44%-33.79% 3.96B
Average -0.82%+1.11%-9.04%+30.99% 11.13B
Weighted average by Cap. +0.38%+3.31%+5.99%+54.81%

Financials

2024 2025
Net sales 210K 180K 168K 154K 289K 20.09M 295K 1.99M 776K 10.07M 789K 771K 33.34M -
Net income -5.19M -4.45M -4.15M -3.81M -7.15M -497M -7.29M -49.21M -19.18M -249M -19.5M -19.07M -824M -4M -3.43M -3.2M -2.94M -5.52M -383M -5.62M -37.95M -14.79M -192M -15.03M -14.71M -636M
Net Debt -2.48M -2.13M -1.99M -1.82M -3.42M -238M -3.49M -23.55M -9.18M -119M -9.33M -9.13M -395M -3.08M -2.64M -2.46M -2.26M -4.24M -295M -4.32M -29.18M -11.37M -148M -11.56M -11.31M -489M
Logo Nexentis Technologies Inc.
Nexentis Technologies Inc, formerly known as N2OFF, Inc., is an AI and data-driven computational biotech platform focused on mitochondrial biology, precision oncology and inflammatory metabolic diseases. Through its subsidiary MitoCareX Bio Ltd. The company uses a proprietary discovery engine targeting the mitochondrial SLC25 carrier family using its MITOLINE algorithm and structure guided virtual screening workflows. MITOLINE, its proprietary computational platform, is designed to allow proper homology modeling of mitochondrial membrane proteins, particularly transport proteins. It enables three-dimensional structural modeling and large-scale virtual screening, MITOLINE opens access to a novel untapped target space, allowing the Company to identify small-molecule modulators that directly disrupt cancer metabolism with the potential of minimizing systemic toxicity.
Employees
8
Date Price Change Volume
26-08-20 US$1.800 -5.76% 44,025
26-08-19 US$1.910 -3.54% 12,677
26-08-18 US$1.980 +2.06% 25,152
26-08-17 US$1.940 +1.57% 16,085
26-08-14 US$1.910 -2.05% 13,749
  1. Stock Market
  2. Stocks
  3. NXTS Stock